Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Outlier detection in bioavailability/bioequivalence studies.

S C Chow1, S K Tse

  • 1Biostatistics, Bristol-Myers, U.S. Pharmaceutical Group, Evansville, IN 47721.

Statistics in Medicine
|May 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A preliminary screening of potentially antimalarial plants against Plasmodium falciparum in vitro.

Tropical biomedicine·2021
Same author

The aminopeptidase inhibitor, z-L-CMK, is toxic and induces cell death in Jurkat T cells through oxidative stress.

Toxicology mechanisms and methods·2017
Same author

Functional characterisation of hepatitis B viral X protein/microRNA-21 interaction in HBV-associated hepatocellular carcinoma.

Hong Kong medical journal = Xianggang yi xue za zhi·2016
Same author

The inhibition of human T cell proliferation by the caspase inhibitor z-VAD-FMK is mediated through oxidative stress.

Toxicology and applied pharmacology·2014
Same author

The cathepsin B inhibitor, z-FA-CMK is toxic and readily induced cell death in human T lymphocytes.

Toxicology and applied pharmacology·2013
Same author

Dexamethasone (DEX) induces Osmotic stress transcription factor 1 (Ostf1) through the Akt-GSK3β pathway in freshwater Japanese eel gill cell cultures.

Biology open·2013
Same journal

Interpretable Bayesian Modeling for Multireader Multicase Studies: Addressing Overdispersion and Limited Sample Size in Diagnostic Enhancement Evaluation.

Statistics in medicine·2026
Same journal

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance.

Statistics in medicine·2026
Same journal

Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta-Diversity.

Statistics in medicine·2026
Same journal

Optimal Weighted Tests for Replication Studies and the 'Two-Trials Rule' With Multiple Hypotheses.

Statistics in medicine·2026
Same journal

Identifiable Copula-Double-Cox Models: A Fully Parametric Framework for Dependent Right-Censored Survival Data.

Statistics in medicine·2026
Same journal

Moving From Individualized Risk-Based Prevention to Benefit-Based Prevention: Estimating Individualized Life-Years Gained From Prevention Services as a Basis for Eligibility.

Statistics in medicine·2026
See all related articles

This study introduces two methods, likelihood distance and estimates distance, to detect outliers in bioavailability and bioequivalence studies. Identifying extreme values is crucial for accurate drug formulation comparisons.

Area of Science:

  • Pharmacokinetics and Drug Development
  • Statistical Methods in Clinical Trials

Background:

  • Outliers in bioavailability/bioequivalence studies can significantly impact the assessment of drug formulation equivalence.
  • Accurate statistical analysis is essential for reliable bioequivalence decisions in pharmaceutical research.

Purpose of the Study:

  • To present and discuss novel techniques for detecting potential outliers in bioavailability/bioequivalence studies.
  • To introduce the likelihood distance and estimates distance procedures for identifying extreme observations.

Main Methods:

  • Development of two outlier detection procedures: likelihood distance and estimates distance.
  • Analysis within a general crossover model framework, accounting for period and formulation effects.
  • Demonstration of the procedures' relationship to a chi-square distribution with three degrees of freedom.

Related Experiment Videos

Main Results:

  • The proposed likelihood distance and estimates distance methods effectively identify potential outliers.
  • The statistical properties of these tests are characterized, linking them to a known distribution.

Conclusions:

  • The presented outlier detection techniques provide robust tools for bioavailability/bioequivalence studies.
  • Illustrative examples confirm the significant influence of outlying values on bioequivalence outcomes.
  • These methods enhance the reliability of statistical decisions in pharmaceutical drug development.